BIOFRONTERA AG NA O.N./ DE0006046113 /
2024-04-23 8:02:14 AM | Chg. -0.0380 | Volume | Bid8:02:14 AM | Ask8:02:14 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
0.3320EUR | -10.27% | 0 Turnover: 0.0000 |
0.3320Bid Size: 1,000 | 0.3580Ask Size: 1,000 | 19.62 mill.EUR | 0.00% | 0.50 |
Fundamentals
FY 2021 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 0.69 EUR | - |
EPS Diluted: | 0.68 EUR | - |
Revenues per Share: | 0.51 EUR | -19.98% |
Book Value per Share: | 1.02 EUR | 559.84% |
Cash Flow per Share: | 0.54 EUR | - |
Dividend per Share: | 0.00 EUR | - |
Total | in mill. | |
Revenues: | 28.80 EUR | -4.95% |
Net Income: | 38.30 EUR | - |
Operating Cash Flow: | 30.40 EUR | - |
Cash and Cash Equivalents: | 6.90 EUR | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 0.50 | 2.14 |
P/S Ratio: | 0.68 | 2.91 |
P/BV ratio: | 0.34 | 1.45 |
P/CF Ratio: | 0.65 | 2.76 |
PEG: | - | - |
Earnings Yield: | 199.42% | 46.62% |
Dividend Yield: | 0.00% | 0.00% |
Market Capitalization | ||
Market Capitalization: | 19.62 mill. EUR | 83.94 mill. EUR |
Free Float Market Cap.: | 9.11 mill. EUR | 38.96 mill. EUR |
Market Cap. / Employee: | 120,393.1411 EUR | 514,976.4417 EUR |
Shares Outstanding: | 56.72 mill. |
Profitability
Gross Profit Margin: | 86.46% |
EBIT Margin: | 85.76% |
Net Profit Margin: | 132.99% |
Return on Equity: | 66.03% |
Return on Assets: | 49.93% |
Financial Strength
Liquidity I / Cash Ratio: | 42.29% |
Liquidity II / Quick Ratio: | 46.86% |
Liquidity III / Current Ratio: | 82.29% |
Debt / Equity Ratio: | 32.24% |
Dynam. Debt / Equity Ratio: | 61.51% |
Efficiency
Employees: | 163 |
Personal Expenses / Employee: | 120,858.90 EUR |
Revenues / Employee: | 176,687.12 EUR |
Net Income / Employee: | 234,969.33 EUR |
Total Assets / Employee: | 470,552.15 EUR |
* Fiscal Year End: | 2021-12-31 |
Accounting Standard: | IFRS |
Currency: | EUR |